In prostate cancer, surviving cells after high-dose radiation have an enhanced sphere-forming capacity and high expression of the CSC marker CD44, and this stemness profile is progressively enhanced within one week after irradiation 40. This evidence concerns the gene CD44 and prostate carcinoma.